Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

Clinical trial NCT03221257 · COMPLETED

Trial details

NCT number: NCT03221257
Sponsor: Michael Roth
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Scleroderma, Systemic Interstitial Lung Disease

Start date: 2017-11-28
Primary completion: 2022-03-23
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.